US6877931096
US6877931096
Oscar Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10.3B EUR | 8.8B EUR | 3.43B EUR | 4.28B EUR |
Enterprise Value | 2.14B EUR | 5.16B EUR | -943.09M EUR | 1.93B EUR |
Valuation Multiples | ||||
Trailing P/E | 25.87x | 15.98x | -- | -- |
Forward P/E | 15.41x | -- | -- | -- |
Price to Sales | 0.67x | 0.57x | 0.26x | 0.49x |
Price to Book | 5.01x | 4.29x | 2.06x | 4.38x |
EV/Revenue | 0.14x | 0.34x | -0.07x | 0.22x |
EV/EBITDA | 3.25x | -- | -- | -- |
Price to FCF (P/FCF) | 14.87x | 2.01x | 1.23x | 22.64x |
EV/FCF | 3.08x | 1.18x | -0.34x | 10.23x |
FCF Yield | 6.72% | 49.76% | 81.58% | 4.42% |